Answers are grounded in this paper and cite their sources.
Introduction: Noninvasive assessment of human epidermal growth factor receptor 2 (HER2) status and metastatic burden in colorectal cancer remains challenging. Multimodal positron emission tomography (PET)/magnetic resonance (MR) radiomics offers an opportunity for integrated molecular and metastatic characterization. Objective: To develop and internally validate an exploratory PET/MR radiomics framework for the preoperative prediction of HER2 status and metastatic burden (non-regional lymph nodes) in colorectal cancer (CRC) patients. Methods: This retrospective study incorporated 61 samples with pathologically confirmed CRC who underwent preoperative 18F-fluorodeoxyglucose PET/MR imaging. HER2 positivity was defined according to the refined HER2 Amplification for CRC Enhanced Stratification criteria. Metastatic burden was categorized into three groups based on preoperative imaging: non-metastatic, regional lymph node metastasis, and distant metastasis. Tumor regions were manually segmented on PET, T1- and T2-weighted imaging (T1WI, T2WI), and 2,264 radiomic features were extracted from each imaging modality. Feature selection was performed using a comprehensive multi-step pipeline. An extreme gradient boosting (XGBoost)-based model was then developed and internally validated via 5-fold cross-validation, with performance metrics reported as mean ± standard deviation. Results: For HER2 status prediction, the multimodal combined XGBoost model demonstrated superior performance compared to single-modality models, yielding a mean AUC of 0.9214 ± 0.0779. For metastatic burden prediction, the combined model further excelled, yielding an AUC of 0.827 ± 0.136. SHapley Additive exPlanations analysis revealed imaging signatures for the two prediction tasks. HER2 status prediction was primarily driven by texture-related features, particularly those derived from the Gray-Level Run Length Matrix, Gray-Level Co-occurrence Matrix, and First-order matrices, whereas metastatic burden prediction relied mainly on multiscale texture descriptors from the first-order, Neighborhood Gray-Tone Difference Matrix, and Gray-Level Dependence Matrix. Conclusion: PET/MR radiomics offers an exploratory approach for future risk stratification in CRC, although independent validation is required to confirm clinical utility.
No takes yet. Share an insight, caveat, or question.
Yuan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: